Nanjing Leading Medical Technology Co., Ltd.

Home page

WHX Concludes | Multiple Consensuses Reached, Further Expanding the Global Cooperation Network

Under the warm Dubai sun, the WHX exhibition has reached its final day. Over the course of the few days, H2.H18 The exhibition booth acted like a magnet, drawing the attention of the global diagnostics industry and helping us map out a clear landscape of collaborative opportunities.

Abundant achievements, exceeding expectations:

European market : Reached a consensus with two well-known companies to advance the European clinical validation and regulatory registration of innovative projects.

Middle East core region : We have finalized arrangements with partners from the United Arab Emirates and Saudi Arabia for their public hospital systems. “Comprehensive Diabetes Testing Solution” Pilot program.

Emerging markets : We have received more than ten submissions from Central Asia, North Africa, and other regions regarding Large‑volume reagents and core raw materials Detailed inquiries and intentions for cooperation.

Notably, a long-time South European customer paid a special visit and remarked: “We have witnessed Liding’s transformation from a product supplier to a technology partner. Your relentless innovation and consistent quality are the very sources of our confidence in making long-term plans for the local market.”

The conclusion of the exhibition marks the beginning of new collaborations. Our international business team has meticulously compiled each request, and in the days ahead, in-depth technical discussions, sample testing, and commercial negotiations will proceed in an orderly manner.

Thank you to all our new and longtime friends who have visited. Because we’ve met, we believe; because we walk this path together, we can reach far. We look forward to writing the next chapter of Leading Medical’s global story alongside you.

The exhibition has concluded, but our services continue. We’ll see you online—let’s build the future together.